Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.030 CAD
−3.78 M CAD
827.41 K CAD
106.83 M
About APPILI THERAPEUTICS INC
Sector
CEO
Don Cilla
Headquarters
Halifax
Website
Founded
2015
FIGI
BBG00PH28LQ8
Appili Therapeutics, Inc. operates as a biopharmaceutical company, which acquires and develops novel treatments targeting unmet needs in infectious disease. It focuses on building and advancing a diverse portfolio of anti-infective programs such as ATI-1501, ATI-1503, and ATI-1701. The company was founded on May 7, 2015 and is headquartered in Halifax, Canada.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of APLI is 0.035 CAD — it has decreased by −12.50% in the past 24 hours. Watch APPILI THERAPEUTICS INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TSX exchange APPILI THERAPEUTICS INC stocks are traded under the ticker APLI.
APLI stock hasn't changed in a week, the month change is a 16.67% rise, over the last year there was no change in APPILI THERAPEUTICS INC price.
APLI reached its all-time high on May 20, 2020 with the price of 1.890 CAD, and its all-time low was 0.025 CAD and was reached on Jul 11, 2023. View more price dynamics on APLI chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
APLI stock is 0.00% volatile and has beta coefficient of 1.83. Track APPILI THERAPEUTICS INC stock price on the chart and check out the list of the most volatile stocks — is APPILI THERAPEUTICS INC there?
Today APPILI THERAPEUTICS INC has the market capitalization of 4.24 M, it has increased by 14.29% over the last week.
Yes, you can track APPILI THERAPEUTICS INC financials in yearly and quarterly reports right on TradingView.
APPILI THERAPEUTICS INC is going to release the next earnings report on Feb 18, 2025. Keep track of upcoming events with our Earnings Calendar.
APLI net income for the last quarter is −1.58 M CAD, while the quarter before that showed −1.10 M CAD of net income which accounts for −43.63% change. Track more APPILI THERAPEUTICS INC financial stats to get the full picture.
No, APLI doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 13, 2024, the company has 7.00 employees. See our rating of the largest employees — is APPILI THERAPEUTICS INC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. APPILI THERAPEUTICS INC EBITDA is −8.59 M CAD, and current EBITDA margin is −968.03%. See more stats in APPILI THERAPEUTICS INC financial statements.
Like other stocks, APLI shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade APPILI THERAPEUTICS INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So APPILI THERAPEUTICS INC technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating APPILI THERAPEUTICS INC stock shows the sell signal. See more of APPILI THERAPEUTICS INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.